Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
Idexx Laboratories Operating Lease Right-of-Use Assets in Other Assets decreased by 1.5% to $121.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $116.00M to $121.40M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows an upward trend with a 6.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2025
Last reportedQ1 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $104.72M | $106.96M | $105.10M | $107.74M | $115.46M | $110.10M | $118.62M | $115.06M | $114.15M | $117.78M | $115.50M | $119.89M | $119.53M | $121.05M | $116.13M | $116.00M | $129.78M | $128.21M | $123.23M | $121.40M |
| QoQ Change | — | +2.1% | -1.7% | +2.5% | +7.2% | -4.6% | +7.7% | -3.0% | -0.8% | +3.2% | -1.9% | +3.8% | -0.3% | +1.3% | -4.1% | -0.1% | +11.9% | -1.2% | -3.9% | -1.5% |
| YoY Change | — | — | — | — | +10.3% | +2.9% | +12.9% | +6.8% | -1.1% | +7.0% | -2.6% | +4.2% | +4.7% | +2.8% | +0.5% | -3.2% | +8.6% | +5.9% | +6.1% | +4.7% |
Range$104.72M – $129.78M
CAGR+3.2%
Avg YoY Growth+4.4%
Median YoY Growth+4.7%
Current Streak3 quarters decline
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's operating lease right-of-use assets in other assets?
- Idexx Laboratories (IDXX) reported operating lease right-of-use assets in other assets of $121.40M in Q1 2026.
- How has Idexx Laboratories's operating lease right-of-use assets in other assets changed year-over-year?
- Idexx Laboratories's operating lease right-of-use assets in other assets increased by 4.7% year-over-year, from $116.00M to $121.40M.
- What is the long-term trend for Idexx Laboratories's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Idexx Laboratories's operating lease right-of-use assets in other assets has grown at a 6.2% compound annual growth rate (CAGR), from $91.17M to $123.23M.